The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation

Journal of Pediatric Gastroenterology and Nutrition

Volumn 28, Issue 4, 1999, Pages 380-385

  Younes, Bassam S ^a   Ament, Marvin E ^a,b   McDiarmid, Sue V ^a   Martin, Martin G ^a   Vargas, Jorge H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Gastrointestinal; Orthotopic liver transplantation; Posttransplant lymphoproliferative disease

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; DISEASE ASSOCIATION; ENDOSCOPY; ENTEROPATHY; GASTROINTESTINAL HEMORRHAGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; HUMANS; IMMUNOSUPPRESSION; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; RETROSPECTIVE STUDIES; SERUM ALBUMIN; WEIGHT LOSS;

EID: 0033512211     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199904000-00007     Document Type: Article

References (27)

1. Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 1996;62:370-5.
2. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasia and lymphomas in renal transplant recipients. Cancer Res 1981;41:4262-79.
3. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A - prednisone immunosuppression. Am J Pathol 1988;133:173-92.
4. Seiden MV, Sklar J. Molecular genetic analysis of post-transplant lymphoproliferative disorders. Hematol Oncol Clin North Am 1993;7:447-65.
5. Rustgi VK. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders. Liver transplantation and Surgery 1995;117(suppl):100-8.
6. Hart J, Lewin KJ. Liver allograft pathology. In: Ferrell LD, eds. Pathology: State of the art review. Philadelphia: Hanley and Belfus, 1994:207.
7. Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. Am J Surg Pathol 1990;14 Suppl 1:92-100.
8. Kahn E. Gastrointestinal manifestations in pediatric AIDS. Pediatr Pathol Lab Med 1997;17:171-208.
9. Mc Diarmid SV. Liver transplantation in children. In: Cosimi AB, Ginns L, Morris PJ. eds. Transplantation. Cambridge, MA: Blackwell Science, Inc. (in press).
10. Esquivel CO, So SK, McDiarmid SV, Andrews WS, Colombani PM. Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients (letter). Transplantation 1996;61:847-8.
11. Martinez OM, Villaneuva JC, Lawrence-Miyasaki LS, Quinn MB, Cox K, Krams SM, Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation 1995;59:519-24.
12. McDiarmid SV, Jordan S, Geoff L, et al. Prevention and preemptive therapy of post-transplant lymphoproliferative disease in pediatric liver recipients. Transplantation (in press).
13. Morrison VA, Dunn DL, Maniyel JC, Gajl-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994;97:14-24.
14. Penn I. Posttransplant malignancies in pediatric organ transplant recipients. Transplant Proc 1994;26:2763-5.
15. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children. Transplantation 1988; 45:719-27.
16. Lamy M, Favart AM, Cornu C, et al. Epstein-Barr virus infection in 59 orthotopic liver transplant patients. Med Microbiol Immunol 1990;179:137-44.
17. Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JE. Epstein-Barr virus serology and Epstein-Barr associated lymphoproliferative disorders in pediatric liver transplant patients. Transplantation 1993;56:1394-8.
18. Starzl TE. Discussion of Murray JE, Wilson RE, Tilney NL, et al. Five years' experience in renal transplantation with immunosuppressive drugs: Survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg 1968;168: 416-35.
19. Cao S, Cox K, Esquivel CO, et al. PTLD and gastrointestinal manifestations of EBV infection in children following liver transplantation. Abstract presented at that meeting of American Society of Transplant Physicians, Dallas, Texas, 1996.
20. McDiarmid SV, Busutill RW, Ascher NL, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 1995;59: 530-6.
21. Van Thiel DH, Iqbal M, Jain A, et al. Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK506 in liver transplantation. Transplant Proc 1990; 22(Suppl):37-40.
22. Benkerrou M, Durandy A, Fisher A. Therapy for transplant-related lymphoproliferative diseases. Hematol Oncol Clin North Am 1993; 7:467-75.
23. Frayha HH, Nazer H, Kalloghlian A, Antonius JI, Sabbah R. Lymphoproliferative disorder in a liver transplant patient on FK 506 (letter). Lancet 1991;337:296-97.
24. Cox KL, Lawrence LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995;59:524-29.
25. Forman SJ, Sullivan JL, Wright C, et al. Epstein-Barr virus related malignant B cell lymphoplasmacytic lymphoma following allogeneic bone marrow transplantation for aplastic anemia. Transplantation 1987;44:244-49.
26. David A. Thorley-Lawson. Basic virological aspects of Epstein-Barr virus infection. Semin Hematol 1988;25:247-60.
27. Fisher A, Schwartz M, Mor E, et al. Gastrointestinal toxicity associated with FK 506 in liver transplant recipients. Transplant Proc 1994;26:3106-7.